Lepu Biotech announced on the Hong Kong Stock Exchange that on January 22, 2025, the company entered into an exclusive licensing agreement with ArriVent Biopharma, Inc. (which is listed on the Nasdaq global market). The company grants ArriVent an exclusive license to develop and commercialize the group's innovative antibody-drug conjugate MRG007 on a global basis (excluding Greater China). According to the licensing agreement, the company grants ArriVent an exclusive license regarding the intellectual property rights related to MRG007 owned or controlled by the group. The company will receive a one-time upfront payment and recent milestone payments totaling 47 million USD, and up to 1.16 billion USD in development, registration, and sales milestone payments, as well as tiered royalties ranging from high single digits to low double digits of future net sales of MRG007 in the licensed regions.

- Latest
- Detail
乐普生物:与ArriVent就创新型ADC MRG007订立独家许可协议
Lepu Biotech: Entered into an exclusive licensing agreement for the innovative ADC MRG007 with ArriVent.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Latest
11:31
ETF midday review: The Hong Kong Stock Connect 50 ETF leads with an increase of 8.23%, while the Sci-Tech Chip ETF from Fuguo falls by 15.78%.
Guotai CSI HK Equities 50 ETF+8.78%
11:28
The Thai stock index SET Index rose by more than 1%.
11:27
Alibaba Cloud's second Datacenter in Thailand is now operational, accelerating its expansion in Southeast Asia.
BABA+4.92%
Investment Course

Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.